STIM — Neuronetics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1227636 ·
Last close
$1.98
Market Cap
$137.78M
52W High
$2.47
52W Low
$1.12
ADV30
1,931,550
Next earnings
2026-08-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 34,454,000 | 16,154,000 | -8,995,000 | -10,790,000 | 125,440,000 | 13,214,000 | 108,380,000 |
| Dec 2025 | 41,777,000 | 21,704,000 | -5,043,000 | -7,158,000 | 141,551,000 | 28,134,000 | 115,311,000 |
| Sep 2025 | 37,297,000 | 17,108,000 | -7,321,000 | -9,045,000 | 145,465,000 | 27,971,000 | 114,105,000 |
| Jun 2025 | 38,108,000 | 17,758,000 | -8,058,000 | -10,120,000 | 134,650,000 | 10,969,000 | 103,143,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,374,000
Investing CF
$-801,000
Financing CF
$35,850,000
CapEx
$-801,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.59
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-458,787,000
Inventory
$4,327,000
Receivables
$16,893,000
ST Investments
$225,000
EBIT TTM
$-31,520,000
Pretax Income TTM
$-39,120,000
Interest Exp TTM
$7,600,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$151,636,000
EBITDA
$-25,778,000
Free Cash Flow
$-4,582,000
Enterprise Value
$213,752,928
Total Cash
$13,214,000
Total Debt
$85,388,000
Shares Out
69,587,840
Trailing EPS
$-0.54
Book Value
$0.19
ROE
-131.6%
ROA
-13.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 149,157,000 | -31,436,000 | -38,998,000 | 141,551,000 | 115,311,000 | — | -20,374,000 |
| Dec 2024 | 74,890,000 | -34,563,000 | -43,708,000 | 140,903,000 | 109,104,000 | — | -30,997,000 |
| Dec 2023 | 71,348,000 | -30,554,000 | -30,189,000 | 115,831,000 | 81,641,000 | — | -32,038,000 |
| Dec 2022 | 65,206,000 | -35,111,000 | -37,159,000 | 116,884,000 | 59,824,000 | — | -30,739,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.34
Max Pain — expiry 2026-08-21
max pain strike: $1.00 · spot: $1.98 · call oi: 4,479 · put oi: 387
Expected Move to 2026-08-21:
±$0.79
(39.90%) —
implied range
$1.19 –
$2.77
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CVRX | CVRx, Inc. | $137.32M | $5.18 | — |
| NYXH | Nyxoah SA | $140.10M | $1.40 | — |
| RCEL | AVITA Medical, Inc. | $135.42M | $4.40 | — |
| AVHHL | AVITA Medical, Inc. | $135.42M | $0.88 | — |
| STXS | Stereotaxis, Inc. | $125.53M | $1.26 | — |
News headlines (Yahoo Finance, 1h cache)
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-07-31 21:00 · Yahoo
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
2026-07-28 12:32 · Yahoo
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
2026-07-28 12:30 · Yahoo
Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day
2026-07-24 11:19 · Yahoo
Bull of the Day: Brainsway (BWAY)
2026-07-24 08:30 · Yahoo
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
2026-07-20 20:05 · Yahoo
Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit
2026-07-14 18:08 · Yahoo
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
2026-07-06 12:30 · Yahoo
Neuronetics Appoints Robert Greene as Senior Vice President Sales
2026-06-02 20:30 · Yahoo
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
2026-06-02 12:32 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.